Nicolaus Andratschke
Papers
3
Total Citations
197
H-Index
3
About
Nicolaus Andratschke is a leading radiation oncologist whose research focuses on stereotactic body radiotherapy (SBRT) for oligometastatic disease, particularly in the liver, and the emerging field of cardiac radioablation. His major contributions include spearheading the German Society for Radiation Oncology (DEGRO) SBRT database initiative, which analyzed patterns of care and outcomes for liver oligometastases in a landmark study of 474 patients with 623 metastases—a work cited over 150 times that established key factors influencing tumor control and survival. He also advanced robotic-guided SBRT for liver metastases, demonstrating that mean GTV dose optimization with real-time motion compensation yields excellent efficacy and low toxicity. More recently, Dr. Andratschke has been instrumental in the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial, where he led a multicenter, multiplatform benchmarking study to standardize treatment planning for cardiac radioablation. His work bridges technical innovation with clinical practice, shaping guidelines for SBRT in both oncologic and cardiac indications. With a growing citation impact and leadership in national trials, he is a key figure in modern precision radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3